Furthermore, its interpretability enables the identification of critical cancer-associated genes, with experimental validation uncovering three novel genes—PCDHA10, PRICKLE2, and PRTG—that exhibit inhibitory effects on breast cancer cell proliferation and migration. The gene discussed is PRTG; the disease is breast carcinoma.